ENDOG and endometrial carcinoma: In addition, although the effects on proliferation due to the reduction in ENDOG/Endog gene expression in somatic cells was ROS-dependent [8], this was not observed in IK endometrial carcinoma cells in which pharmacological ROS neutralization does not restore proliferation.